TL;DR
Leprosy cases are rising in Florida, a state that already accounts for a significant share of U.S. diagnoses, and the disease is no longer exclusively tied to foreign travel. While the overall risk remains extremely low, Florida clinicians are seeing locally acquired infections, making awareness and early detection critical for preventing permanent nerve damage.
What Happened
Florida is reporting a steady climb in leprosy cases, according to a new report from NewsNation, challenging the long-held assumption that the disease is almost always imported from abroad. The report, published August 6, 2026, highlights that while leprosy—also known as Hansen's disease—remains rare in the U.S., most Americans who contract it have historically done so while traveling internationally, but that pattern is shifting within the Sunshine State.
Key Facts
- Florida reported more than 20 new leprosy cases in the most recent tracking period, a notable increase from prior years and one of the highest state totals in the nation, according to the National Hansen's Disease Program.
- The Centers for Disease Control and Prevention (CDC) estimates that roughly 150 to 200 people are diagnosed with leprosy in the U.S. each year, with Florida, California, and Texas consistently reporting the highest numbers.
- Central Florida has emerged as a particular hotspot, with health officials noting that some patients report no history of international travel, suggesting local transmission is occurring.
- The disease is caused by the bacterium Mycobacterium leprae, which primarily affects the skin, peripheral nerves, and mucous membranes; it is not highly contagious and spreads through prolonged, close contact with untreated individuals.
- About 95% of people have natural immunity to leprosy, according to the World Health Organization (WHO), meaning even significant exposure rarely results in infection.
- The incubation period for leprosy can range from one to 20 years, making it difficult for patients and doctors to identify when and where exposure occurred.
- Armadillos in the southeastern U.S. are a known natural reservoir for the bacteria, and direct contact with the animals has been linked to some human cases in Florida and neighboring states.
Breaking It Down
The rise in Florida's leprosy cases is not a public health emergency in the classic sense—the disease is curable with a multi-drug regimen and is not easily transmitted—but it signals something important about how infectious diseases are re-emerging in unexpected places. For decades, U.S. clinicians have been trained to ask leprosy patients about overseas travel, particularly to countries like India, Brazil, and Indonesia, where the disease is more prevalent. That diagnostic reflex is now being complicated by evidence of locally acquired infections in Florida, which means physicians must broaden their clinical suspicion.
Central Florida has reported cases in individuals with no travel history and no known contact with armadillos, which suggests that an unknown environmental or human transmission chain may be at play.
This is the most striking aspect of the current data. If leprosy is circulating in the community without a clear source, it implies that the bacterium may be more established in the region than previously understood. The National Hansen's Disease Program in Baton Rouge, Louisiana, has been tracking these cases closely, and clinicians there have noted that the demographic profile of U.S. patients is shifting—no longer dominated by immigrants from endemic countries, but increasingly including U.S.-born residents in the Southeast.
The clinical challenge is significant because leprosy presents with a range of symptoms—skin lesions, numbness, and weakness—that can mimic other dermatological or neurological conditions. Delayed diagnosis is common, and by the time the disease is identified, nerve damage may already be irreversible. For Florida's healthcare system, this means a renewed emphasis on physician education and awareness, particularly among primary care providers and dermatologists who are most likely to encounter early-stage cases.
Public perception also matters. The word "leprosy" carries a heavy historical stigma, and health officials are working to reassure the public that the disease is not easily spread and that casual contact—handshakes, shared meals, or sitting next to someone—poses essentially no risk. The WHO has called for eliminating leprosy-related stigma as part of its global strategy, and Florida's public health messaging is now echoing that sentiment as case numbers tick upward.
What Comes Next
The Florida Department of Health and the CDC are expected to release updated surveillance data in the coming months, which will provide a clearer picture of whether the current increase is a one-year anomaly or part of a sustained trend. Epidemiologists will be looking closely at whether cases cluster in specific counties or share any common risk factors, which could help identify a transmission source.
- CDC surveillance report: The next quarterly update from the National Hansen's Disease Program is expected in late September 2026, which will include case counts by state and county, as well as any new information on transmission patterns.
- Florida Department of Health guidance: State health officials are expected to issue updated clinical guidance for physicians by the end of October 2026, focusing on diagnostic criteria and when to consider leprosy in patients without travel history.
- Armadillo research: Researchers at the University of Florida are continuing a study on armadillo populations in Central Florida to assess the prevalence of Mycobacterium leprae in the wild, with preliminary findings slated for release in early 2027.
- WHO global strategy review: The World Health Organization is scheduled to publish its biennial progress report on leprosy elimination in December 2026, which will include updated U.S. data and global comparisons.
The Bigger Picture
This story sits at the intersection of two broader health trends: the re-emergence of historically controlled diseases and the impact of climate and ecological change on disease geography. As Florida's climate warms and its human population expands into previously undeveloped areas, contact with wildlife reservoirs—including armadillos—is increasing. This same dynamic is playing out with other zoonotic diseases across the country, from Lyme disease expanding into new regions to dengue fever appearing in southern states.
The second trend is the growing importance of domestic infectious disease surveillance. For years, U.S. public health resources have been heavily oriented toward detecting and responding to imported diseases, from Ebola to COVID-19 variants. But the Florida leprosy cases are a reminder that homegrown transmission can occur even for diseases considered rare or eliminated. This has implications for how states fund and staff their epidemiology programs, and it underscores the need for clinicians to maintain a broad differential diagnosis rather than defaulting to travel-related explanations.
Key Takeaways
- Rising Florida cases: Leprosy is increasing in Florida, with locally acquired infections now documented, meaning the disease is no longer solely a travel-related condition in the U.S.
- Low transmission risk: The disease is not highly contagious—95% of people have natural immunity—and it requires prolonged, close contact with an untreated person to spread.
- Early diagnosis is critical: Because leprosy can take up to 20 years to manifest symptoms and causes irreversible nerve damage if untreated, clinicians must maintain a high index of suspicion.
- Environmental factors matter: Armadillos are a known reservoir in the Southeast, and increased human-wildlife contact may be contributing to the uptick in cases.
